Answers are grounded in this paper and cite their sources.
L-Asparaginase-induced coagulation abnormalities were observed in all patients receivng this drug. All patients studied demonstrated low factor IX and fibrinogen levels and most (75%) had low levels of factor XI. Disturbances in other factors were much less frequent. Despite the presence of markedly abnormal coagulation studies, clinical bleeding was not observed.
No takes yet. Share an insight, caveat, or question.
Sills et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: